Raul Gainetdinov | |
---|---|
![]() | |
Born | Raul R. Gainetdinov September 1, 1964 |
Known for | TAAR Dopamine receptors |
Scientific career | |
Fields | Neuropsychopharmacology Medicine Biology |
Institutions | Duke University Italian Institute of Technology Saint Petersburg University |
Academic advisors |
Raul Gainetdinov (born September 1, 1964) is a pharmacologist and neuroscientist. The main direction of his research is psychiatric and neurological diseases of the brain, such as schizophrenia, ADHD, depression and Parkinson's disease. He is the author of fundamental scientific works in pharmacology of dopamine, [1] β-Arrestins [2] [3] and NMDA receptors. [4] He is a pioneer researcher of Trace amine-associated receptors. [5] [6] [7]
He earned an MD degree from the Second Moscow Medical Institute (now the Russian National Research Medical University) in 1988, followed by a PhD degree in Pharmacology in 1992 from the Russian Academy of Medical Sciences. [8]
Since 2018 Raul Gainetdinov has been included in the Web of Science Highly Cited Researchers list. [13] [14] h-index 82. [15]
Since 2013 he has been the chairman of the nomenclature committee for dopamine receptors of International Union of Basic and Clinical Pharmacology (IUPHAR). [16]